Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0960
-0.0040 (-4.00%)
Jul 3, 2025, 10:50 AM EDT
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $9.08 million as of July 3, 2025. Its market cap has decreased by -67.56% in one year.
Market Cap
9.08M
Enterprise Value
12.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 9.08M, a decrease of -92.31%. That is a compound annual growth rate of -8.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.63B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 640.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 540.25M |
| American Oncology Network | 443.39M |
| Northwest Biotherapeutics | 363.62M |